NF-kappaB inhibitors (Shenzhen Wanhe Pharmaceutical/Aichi Medical/Meiji Pharmaceutical University)

N/A

Report date: 2025/01/26 17:37:01
NME

Base Information

Drug NameNF-kappaB inhibitors (Shenzhen Wanhe Pharmaceutical/Aichi Medical/Meiji Pharmaceutical University)
Drug Alias NameSEMBL
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Wanhe Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiji Pharmaceutical UniversityAichi Medical UniversityShenzhen Wanhe Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A